FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20558911000001100: Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1841171000001113 Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1841181000001110 Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Is a Generic Eviplera 200mg/25mg/245mg tablets true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has specific active ingredient Tenofovir disoproxil fumarate true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has specific active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has specific active ingredient Rilpivirine hydrochloride false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rilpivirine false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Is a Eviplera true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has active ingredient Substance with reverse transcriptase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has active ingredient Tenofovir true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has specific active ingredient Rilpivirine hydrochloride true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rilpivirine true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Has basis of strength substance Rilpivirine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has AMP True Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start